Ray Dalio Becton Dickinson & CO Transaction History

Bridgewater Associates, LP

$23.3 Billion
Q2 2025

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Becton Dickinson & CO stock. As of the latest transaction made, Bridgewater Associates, LP holds 9,376 shares of BDX stock, worth $1.77 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,376

Previous 12,223 23.29%

Holding current value

$1.77 Million

Previous $2.8 Million 42.3%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$165.15 - $226.42 $470,182 - $644,617	-2,847 Reduced 23.29%	9,376 $1.62 Million
Q1 2025 May 14, 2025	SELL	$222.79 - $249.08 $4.41 Million - $4.93 Million	-19,788 Reduced 61.82%	12,223 $2.8 Million
Q4 2024 Feb 13, 2025	SELL	$220.02 - $243.75 $3.23 Million - $3.58 Million	-14,689 Reduced 31.45%	32,011 $7.26 Million
Q3 2024 Nov 13, 2024	SELL	$221.47 - $242.41 $36.2 Million - $39.7 Million	-163,640 Reduced 77.8%	46,700 $11.3 Million
Q2 2024 Aug 14, 2024	SELL	$225.07 - $246.17 $8.91 Million - $9.75 Million	-39,594 Reduced 15.84%	210,340 $49.2 Million
Q1 2024 May 14, 2024	SELL	$233.45 - $247.73 $10.9 Million - $11.6 Million	-46,853 Reduced 15.79%	249,934 $61.8 Million
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $11.8 Million - $13.6 Million	-50,906 Reduced 14.64%	296,787 $72.4 Million
Q3 2023 Nov 13, 2023	BUY	$254.9 - $283.59 $4.77 Million - $5.31 Million	18,708 Added 5.69%	347,693 $89.9 Million
Q2 2023 Aug 11, 2023	SELL	$238.39 - $265.32 $11 Million - $12.2 Million	-45,945 Reduced 12.25%	328,985 $86.9 Million
Q1 2023 May 12, 2023	BUY	$229.71 - $259.35 $2.38 Million - $2.69 Million	10,372 Added 2.85%	374,930 $92.8 Million
Q4 2022 Feb 13, 2023	SELL	$218.29 - $256.91 $7.89 Million - $9.29 Million	-36,142 Reduced 9.02%	364,558 $92.7 Million
Q3 2022 Nov 10, 2022	SELL	$51.03 - $264.23 $2.39 Million - $12.4 Million	-46,895 Reduced 10.48%	400,700 $89.3 Million
Q2 2022 Aug 11, 2022	SELL	$234.74 - $275.42 $13.2 Million - $15.5 Million	-56,302 Reduced 11.17%	447,595 $110 Million
Q1 2022 May 13, 2022	BUY	$243.64 - $270.48 $35.4 Million - $39.3 Million	145,116 Added 40.45%	503,897 $134 Million
Q4 2021 Feb 14, 2022	BUY	$230.08 - $250.94 $13.9 Million - $15.2 Million	60,575 Added 20.31%	358,781 $90.2 Million
Q3 2021 Nov 12, 2021	BUY	$232.72 - $256.47 $11.8 Million - $13 Million	50,739 Added 20.5%	298,206 $73.3 Million
Q2 2021 Aug 13, 2021	BUY	$232.65 - $254.58 $12.2 Million - $13.4 Million	52,457 Added 26.9%	247,467 $60.2 Million
Q1 2021 May 14, 2021	BUY	$232.09 - $256.88 $11.3 Million - $12.5 Million	48,725 Added 33.31%	195,010 $47.4 Million
Q4 2020 Feb 12, 2021	BUY	$221.92 - $245.94 $17.2 Million - $19.1 Million	77,576 Added 112.91%	146,285 $36.6 Million
Q3 2020 Nov 13, 2020	BUY	$215.77 - $276.76 $14.8 Million - $19 Million	68,709 New	68,709 $16 Million
Q2 2020 Aug 12, 2020	SELL	$219.9 - $263.41 $1.87 Million - $2.24 Million	-8,509 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$195.69 - $279.01 $1.67 Million - $2.37 Million	8,509 New	8,509 $1.96 Million
Q4 2017 Feb 13, 2018	SELL	$189.0 - $222.64 $3.63 Million - $4.28 Million	-19,207 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$186.89 - $198.9 $3.59 Million - $3.82 Million	19,207	19,207 $3.76 Million

Others Institutions Holding BDX

# of Institutions

1,742

Shares Held

259M

Call Options Held

1.82M

Put Options Held

696K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $53.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account